ROIV - Roivant Sciences files for $1.5B mixed shelf
2023-09-29 17:45:26 ET
More on Roivant Sciences
- Skin In The Game: Behind Roivant's Significant Rise
- Roivant Sciences Ltd. (ROIV) Q1 2023 Earnings Call Transcript
- Roivant Sciences Ltd. 2023 Q1 - Results - Earnings Call Presentation
- Immunovant to raise $450M from public offering and private placement
- Immunovant stock rallies for second day, fueled by public offering, drug data
For further details see:
Roivant Sciences files for $1.5B mixed shelf